← Leaderboards
Eli Canaani
Thomas Jefferson University
$464,021
Attributed
$464,021
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$464,021 · 2
By mechanism
R01$464,021 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Carlo M Croce$37,904,390
- Bruno Calabretta$9,620,602
- Alexander M Mazo$10,970,170
- David E Birk$14,759,916
- Philip N Tsichlis$14,961,127
Others in their field
Top investigators on “Molecular Oncology”
- Gregory H Reaman · National Childhood Cancer Foundation$243,743,268
- David Heimbrook · Leidos Biomedical Research, Inc.$218,489,003
- Peter C Adamson · National Childhood Cancer Foundation$151,727,370
- Richard L Schilsky · University Of Chicago$115,233,315
- Monica M Bertagnolli · Strang Cancer Prevention Center$101,803,003
- Walter John Curran · Thomas Jefferson University$74,079,477
Research focus
Molecular OncologyNeoplasm /Cancer GeneticsLaboratory MouseChimeric ProteinsOncoproteinsMolecular CloningAcute Lymphocytic LeukemiaChromosome TranslocationChronic Myelogenous LeukemiaClone CellsDifferential Display TechniqueGene Deletion MutationGene ExpressionGene Induction /RepressionGene TherapyGenetically Modified AnimalsGenetic Regulatory ElementHematopoietic Stem CellsHomeobox GenesHuman Genetic Material TagHuman SubjectInterferonsLaboratory RabbitNucleic Acid Sequence
Grant awards (6)
INITIATION AND PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$197,196
R01 · FY2002 · CA
ALL-1 Gene in Malignant and Normal Processes$0
P01 · FY2002 · CA
INITIATION AND PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$197,196
R01 · FY2001 · CA
ALL-1 Gene in Malignant and Normal Processes$0
P01 · FY2001 · CA
INITIATION AND PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA$69,629
R01 · FY2000 · CA
ALL-1 Gene in Malignant and Normal Processes$0
P01 · FY2000 · CA